Track topics on Twitter Track topics that are important to you
SEATTLE, April 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering the expansion of Cansortium (CSE: TIUM). The company, one of Florida’s largest medical marijuana companies and the only one based in the state, with head offices in Miami, is once again expanding its retail presence with the addition of a Knox Medical dispensary in Casselberry, FL.
Cansortium controls one of 14 operating licenses in Florida - a state with the fastest growing medical cannabis patient population in the US - opened Orlando’s first dispensary in 2017. The company’s new location, 10 kilometers northeast of central Orlando, is designed to augment the Orlando dispensary and make it easier for residents in the north and eastern suburbs to obtain medical marijuana, whether in-store or through Knox’s delivery service.
Focus on Quality, Patient Satisfaction
While many of its competitors have saturated the Florida market, Cansortium has taken a far more measured, strategic approach and set itself apart by focusing on high standards and patient needs. Knox Medical dispensaries look more like pharmacies than the head shops which have sprung up throughout the state since the legalization of medical cannabis. Their locations are designed to be highly-visible, easily-accessible, convenient to shop at and get in & out of, and all are wheelchair-accessible. Their interiors are warm, professional, sleek and modern, staffed with knowledgeable salespeople who can guide patients through the process of selecting the right products and understand the importance of safeguarding patient privacy.
Until last month, Florida’s medical patients were limited to extract-based products, but a 2017 ban on the smoking of cannabis flower was finally overturned on March 19, 2019, meaning that as well as offering derivatives such as CBD/THC oils, vapes, tinctures, topical, etc. patients will now be able to obtain flower through Knox Medical, and the new law allows them to receive two and a half ounces of whole flower cannabis every 35 days.
Cansortium’s proprietary cultivation techniques give it an advantage over competitors relying solely on legacy cultivation practices. Its cultivation operations and R&D are overseen by a world-renowned PhD agronomist, and its proprietary drying & terpene extraction process requires only six hours per cycle, as opposed to the six days required using conventional methods, while preserving terpenes and whole plant profiles. The company currently operates a GMP-certified 31,000 sq. ft greenhouse and 9,000 sq. ft processing facility, with an additional 187,000 sq. ft. of cultivation space being added in 2019.
Casselberry will be the tenth Florida Knox Medical dispensary, with an additional thirteen in development and seven more planned.
The Casselberry dispensary is scheduled to open April 12th, 2019 pending final inspection and Cansortium anticipates doing similar numbers to the existing Orlando facility.
The Bigger Picture
Cansortium also has retail, cultivation, and processing operations in Texas, Pennsylvania, Puerto Rico, as well as Colombia – the anticipated hub of the red hot emerging Latin American cannabis market. It’s recently expanded into Canada, the first federally-legalized recreational market in the world, and a domestic expansion into Michigan, where license-holders are allowed an unlimited number of dispensaries, is currently underway. The company is also engaged in strategic expansions into Argentina, Australia, and the emerging European market - which is expected to outpace the US and Canadian markets combined.
Cansortium has a proven record as a successful strategic first-mover in large markets with high barriers to entry, and its extensive regulatory expertise enables it to navigate the steadily-evolving medical cannabis regulatory framework, making it one to keep on your radar as the year progresses.
Keep watching this page, or visit http://cansortium.com/ for more information.
Please follow the link to read the full article: https://www.cannabisfn.com/cansortium-setting-up-shop-in-casselberry-growing-florida-footprint/
About CFN Media
For Visitors and Viewers
CFN Media’s Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.
For Cannabis Businesses & Companies
CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.
Our powerful digital media and distribution platform conveys a company’s message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.
Since 2013, CFN Media has enabled the world’s preeminent cannabis companies to thrive in the capital and public markets.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided onhttp://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...